Loterox loteprednol etabonate 0 regulatory update

PARS submitted an MAA for U.K. marketing approval of Loterox to treat inflammatory ophthalmic conditions. Partner Bausch & Lomb Pharmaceuticals Inc. (Tampa, Fla.) markets the product in the U.S. under...